Dr. William Henry Matthai Jr., MD

Dr. Matthai practices at Penn Presbyterian Medical Center in Philadelphia, Pennsylvania, part of University of Pennsylvania.

Dr. Matthai's NPI, 1699702597, was assigned on June 27, 2006. Dr. Matthai graduated from Vanderbilt University School of Medicine in 1984. Dr. Matthai holds Pennsylvania license MD034664E.

Dr. Matthai's primary practice is Penn Presbyterian Medical Center, at 51 North 39th Street, Philadelphia, PA 19104 in Philadelphia County. The practice phone is (215) 662-8000.

Dr. Matthai's primary practice is Penn Presbyterian Medical Center in Philadelphia, Pennsylvania, part of University of Pennsylvania. The medical group on file is Penn Heart and Vascular Center Cherry Hill.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Matthai practices. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Matthai's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dmand AI has Dr. Matthai's licenses on file in 2 states: Pennsylvania and New Jersey.

CMS data shows 663 Medicare services from Dr. Matthai across 10 procedure codes in 2024, for 347 Medicare patients. Medicare paid $39,881 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 347 Medicare patients who saw Dr. Matthai in 2024. The largest group is 75 to 84, with 145 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 16% are also on Medicaid. Their average risk score is 2.23, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Matthai's median patient age at 74, with 19% women.

In 2024, Dr. Matthai wrote 701 Medicare Part D claims for 102 patients. 80% of them were for generic drugs. CMS names the drug for 607 of them, across 20 drugs with 11 or more claims each, at $104,074 in total drug cost. In 2023, CMS named 708 claims across 20 drugs.

Dmand AI links 13 papers to Dr. Matthai, published from 2016 to 2024. 2020 was the busiest year, with 3. The most frequent topics are Pulmonary Embolism, Thrombolytic Therapy and Acute Coronary Syndrome. Dr. Matthai has published most often in Catheter Cardiovasc Interv. Dr. Matthai's most frequent co-authors are Sameer J. Khandhar, MD, Harold I. Palevsky, MD and Daniel M. Kolansky, MD.

CMS Open Payments shows 162 general payments to Dr. Matthai from 26 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 39% of the total. Boehringer Ingelheim Pharmaceuticals, Inc. paid the most, $7,281.

Dr. Matthai graduated from Vanderbilt University School of Medicine in 1984.